Legislator Case Law & Legislation
DE FR IT EN
Analyze in Legislator
11 04 85 1 • KG LU 11 04 85 1 AI generated

Pharmaceutical Advertising Injunction Upheld

Case Number 11 04 85 1
Court / Authority
Jurisdiction Switzerland · Canton of Lucerne (CH-LU)
Decision Date
Outcome Partially Allowed
Open official source Entscheidsuche mirror Machine-readable Markdown (.md)

Legislator summary

AI generated

The court affirmed the partial granting of preliminary injunctions against a competitor regarding advertising claims for a drug treating renal anemia, holding that for such measures under unfair competition law, an unlawful act and an irreparable disadvantage must be made plausible. The court reasoned that advertising for pharmaceuticals, even in professional media, must comply with unfair competition and drug laws, and that the defendants' claims of industry-wide accepted advertising practices were an inadmissible "unclean hands" defense. Furthermore, the alleged disadvantage to the applicant, stemming from threatened market confusion and dilution, as well as reputational harm, qualified as not easily reparable, justifying the injunction pending the main proceedings.

Legislator headnote

Official

Art. 2 f. UWG; Art. 31 f. HMG; Art. 28c - 28f ZGB. Voraussetzungen für den Erlass vorsorglicher Massnahmen im UWG. Auch in der Fachwerbung haben die Werbeaussagen vor dem UWG und dem Heilmittelrecht standzuhalten. Der nicht leicht wieder gutzumachende Nachteil kann in der drohenden Marktverwirrung und Marktverwässerung bestehen. | UWG (unlauterer Wettbewerb)

Keywords

AI generated
comparative advertising media law comparative law medicinal products partial claim preliminary proceedings

Cited Legislation

AI generated
Art. 14 UWG
Cited as the basis for the application of provisional measures rules from the Swiss Civil Code (ZGB) concerning personality protection.
Art. 3 lit. b UWG
Cited as an example of conduct considered unfair competition.
Art. 3 lit. e UWG
Cited in relation to the unlawfulness of comparative advertising statements.
Art. 32 Abs. 1 HMG
Art. 5 Abs. 3 AWV
Cited in relation to the requirement that drug advertising statements must not be misleading.
Art. 7 Abs. 1 AWV
Cited in relation to the requirement that comparative statements about medicines must be scientifically correct.
Art. 13 lit. a AWV
Cited regarding the prohibition on using the word 'sicher' (safe) in specialist advertising unless qualified.
Art. 13 AWV

Cited Case Law

AI generated
4P.64/2003
Pharmaceutical Comparative Advertising Injunction Dismissed for Lack of Irreparable Harm Proof
BGE 104 II 129
BGE 79 II 412
BGE 102 II 294
AI generated
1F 18 3
Trademark Infringement Preliminary Injunction and Limited Discovery Order
2N 14 52
Mass Email Advertising Consent and Unfair Competition Standing
1B 16 41
Media Company Liability for Defamation in Animal Health Reporting
11 97 170
Beauty Queen Satire Infringement Appeal
01 04 9 1
Atlaslogie Trademark Injunction Denial

Key legal questions extracted by Legislator

AI generated
Art. 14 UWG

Cited as the basis for the application of provisional measures rules from the Swiss Civil Code (ZGB) concerning personality protection.

Art. 2 f. UWG

Cited as the requirement for unlawful conduct, which must be present for provisional measures to be ordered.

Art. 28c - 28f ZGB

Cited as the source for the regulation of provisional measures in unfair competition law.

Art. 3 lit. b UWG

Cited as an example of conduct considered unfair competition.

Art. 3 lit. e UWG

Cited in relation to the unlawfulness of comparative advertising statements.

Art. 32 HMG

Cited in relation to the unlawfulness of advertising statements in the context of drug advertising law.

Art. 5 Abs. 3 AWV

Cited in relation to the requirement that drug advertising statements must not be misleading.

Art. 7 Abs. 1 AWV

Cited in relation to the requirement that comparative statements about medicines must be scientifically correct.

Art. 13 lit. a AWV

Cited regarding the prohibition on using the word 'sicher' (safe) in specialist advertising unless qualified.

Art. 31 f. HMG

Cited in the introductory/summary paragraph regarding the context of the case (drug advertising).

Need to analyze how this precedent applies to your matter?

Cross-reference this judgment against statutes, commentaries, and subsequent citing case law inside Legislator AI.

Open in Legislator →

Full text

Rechtsprechung Luzern

Instanz: · Obergericht

Abteilung: · I. Kammer

Rechtsgebiet: · UWG (unlauterer Wettbewerb)

Entscheiddatum: · 15.07.2004

Fallnummer: · 11 04 85.1

LGVE: · 2004 I Nr. 29

Leitsatz: · Art. 2 f. UWG; Art. 31 f. HMG; Art. 28c - 28f ZGB. Voraussetzungen für den Erlass vorsorglicher Massnahmen im UWG. Auch in der Fachwerbung haben die Werbeaussagen vor dem UWG und dem Heilmittelrecht standzuhalten. Der nicht leicht wieder gutzumachende Nachteil kann in der drohenden Marktverwirrung und Marktverwässerung bestehen.

Rechtskraft: · Diese Entscheidung ist rechtskräftig.